Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas. - Shukla ND; Schroers-Martin JG; Sworder BJ; Kathuria KR; Alig SK; Frank MJ; Miklos DB; Coutre S; Diehn M; Khodadoust MS; Roschewski M; Kurtz DM; et al. (Blood advances, 2024)